10 May 2024 - The Department of Health has published a revised agenda for the July 2024 PBAC meeting.

There are many changes; most of them are minor. The updated agenda includes the following resubmissions:

• Levodopa with carbidopa and entacapone (Lecigon) - new formulation
• Prasugrel hydrochloride (Prasugrel SCP) - new formulation
• Talazoparib tosylate (Talzenna) - new indication

Read PBAC agenda